Literature DB >> 9619719

Long-term survival in cerebral glioblastoma. Case report and critical review of the literature.

F Puzzilli1, A Ruggeri, L Mastronardi, D Di Stefano, P Lunardi.   

Abstract

Glioblastoma multiforme is the most malignant tumor of the glial series. The average survival of patients with this tumor ranges from 6 to 12 months. The case of a patient who survived for more than 11 years after diagnosis of a temporal-occipital glioblastoma which was treated with surgery, radiotherapy and chemotherapy is described. The authors deduce that among patients with glioblastoma multiforme (GM), those with a long disease-free interval after initial diagnosis who undergo multimodal therapy, including aggressive tumor removal, are the most likely long-term survivors (LS). Other factors which appeared to be related to longer survival were younger age and high Karnofsky scores.

Entities:  

Mesh:

Year:  1998        PMID: 9619719     DOI: 10.1177/030089169808400115

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  6 in total

1.  Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma.

Authors:  Prabal Deb; Mehar Chand Sharma; Bal Chander; Ashok Kumar Mahapatra; Chitra Sarkar
Journal:  Childs Nerv Syst       Date:  2005-08-16       Impact factor: 1.475

2.  Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.

Authors:  Pejman Majd; Daniel E O'Connell; Ronald C Kim; Daniela A Bota; Jose A Carrillo
Journal:  CNS Oncol       Date:  2017-03-17

3.  MTH-68/H oncolytic viral treatment in human high-grade gliomas.

Authors:  L K Csatary; G Gosztonyi; J Szeberenyi; Z Fabian; V Liszka; B Bodey; C M Csatary
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

4.  Dosimetry in brain tumor phantom at 15 MV 3D conformal radiation therapy.

Authors:  Larissa Thompson; Humberto Galvão Dias; Tarcísio Passos Ribeiro Campos
Journal:  Radiat Oncol       Date:  2013-07-06       Impact factor: 3.481

5.  A very rare case report of long-term survival: A patient operated on in 1994 of glioblastoma multiforme and currently in perfect health.

Authors:  Riccardo Caruso; Alessandro Pesce; Venceslao Wierzbicki
Journal:  Int J Surg Case Rep       Date:  2017-02-20

6.  Recombinant humanised anti-HER2/neu antibody (Herceptin) induces cellular death of glioblastomas.

Authors:  J-F Mineo; A Bordron; I Quintin-Roué; S Loisel; K L Ster; V Buhé; N Lagarde; C Berthou
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.